TLPH
TLPH
NASDAQ · Pharmaceuticals

Talphera Inc

$1.06
+0.08 (+7.92%)
As of Jun 23, 5:15 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,365.1% upside
Low Target $16.33
Average Target $26.13
High Target $37.99
Current Price $1.06
Current
$1.06
Target
$26.13
$16.33 $26.13 avg $37.99
Scenario Analysis
Bear Case
$16.33
1,440.6%
Low target
Base Case
$26.13
+2,365.1%
Avg target
Bull Case
$37.99
+3,484.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$1.57
-32.5% from high
52-Week Low
$0.38
+178.9% from low
Target vs 52W High
$26.13
+1,564.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%